diagene laboratories inc. (CH-4153 Reinach, Switzerland) is a worldwide operating company (GmbH) in providing comprehensive molecular and pharmacogenomics services as well as genetic tests to improve patient care. diagene laboratories inc. is organized under two divisions, Routine Laboratories and Research Laboratories, with offices in Switzerland (CH-4153 Reinach, Switzerland) and Germany (D-79539 Lörrach, Germany).
diagene is a member of the European Molecular Genetics Quality Network and is specialized on the diagnostics of inherited disorders and the genetic predisposition for specific diseases such as e.g. cardiovascular diseases, neurodegenerative or metabolic diseases in adults.
Founded in 1999, diagene is leading in the diagnostics of familial forms of high cholesterol (familial hypercholesterolemia, familial-defective aqpolipoprotein B-100, familial dysbetalipoproteinemia, familail combined hyperlipidemia, etc.). Besides a large series of genetic analyses, diagene offers also biochemical and daily routine laboratory analyses. Recently, several new gene test have been introduced, one of them for the prediction, of severe side efffects of antiretroviral treatment of patients with HIV, another for the diagnosis of the long qt syndrome.
A large number of university laboratories, hospitals as well as physicians all over Europe are customers of diagene. The research laboratories at diagene carry out all types of biomedical research projects from basic research project (e.g. gene regulation, population genetic research projects) to clinical research projects (phase 2-4 studies) and offer a highly sophisticated statistical evaluation of the results, including e.g. multivariate modeling or epidemiologic and population genetic approaches.
In addition, diagene is involved in the organization of large multicenter scientific studies and is a reference laboratory, particularly for complicated genetic and biochemical analyses
|Prof. André R. Miserez, M.D.
|1994 - ongoing||Head, MED PED Program Switzerland (Program for the early diagnosis of cardiovascular risks, endorsed by the World Health Organization)|
|1997 - 2002||Head, Cardiovascular Risk Clinics, University Hospital Basel, University of Basel|
|1997 - 2003||Head, Cardiovascular Genetics, Institute of Genetics and Biochemistry, University of Basel
|2002 - ongoing||Head, Cardiovascular Risk Clinics, Medical University Clinics Bruderholz, , University of Basel|
|2004 - 2007||President, Protective Medicine Foundation|
Prizes and Affiliations:
Winner of the New Entrepreneurs in Technology and Science (NETS) Prize of the Gebert-Rüf Foundation (2001)
Winner of a Swiss Clinicians Opting for Research (SCORE): A Prize of the Swiss National Science Foundation (1997 - 2002)
Member of the International World Health Organization (WHO) Advisory Board for Familial Hypercholesterolemia
|Who Report on FH|
Coordinator of the Make Early Diagnosis - Prevent Early Death (MED PED) Program in Switzerland
Head, Cardiovascular Risk Clinics, Basel University Hospital Bruderholz